Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

HCP, Inc. (HCP - Analyst Report), a real estate investment trust (REIT), recently announced that it has priced 3.15% senior unsecured notes worth $300 million. These notes are scheduled to mature in 2022 and were priced at 98.888% of their face value to generate 3.28%.The offering is expected to close on July 23, 2012.

The notes offering is expected to generate net proceeds of $293.7 million, which will be utilized to fund future acquisitions and for general corporate purposes.

During the first quarter of 2012, the company issued $450 million of 3.75% senior unsecured notes scheduled to mature in 2019. The net proceeds of approximately $444.0 million from the transaction were utilized to repay the debt under its revolving credit facility and for general corporate purposes.

HCP reported first quarter 2012 FFO (funds from operations) of $264.8 million or 64 cents per share, compared with $149.7 million or 40 cents per share in the year-earlier quarter. Funds from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.

Headquartered in Long Beach, California, HCP is engaged in acquiring, developing, managing, selling and leasing a diverse portfolio of healthcare real estate related properties. The company also provides mortgage and other financing to healthcare providers.

HCP follows a conservative approach to financial management by actively managing its debt-to-equity levels and maintaining multiple sources of liquidity like the revolving credit facility, access to capital markets and secured debt providers, and divesture of assets. The financial flexibility enables the company to take advantage of potential investment opportunities that in turn bolsters top-line growth.

HCP currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock. One of its competitors, Ventas Inc. (VTR - Analyst Report), also has a Zacks #3 Rank.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
GENERAL FINA GFN 8.20 +5.67%
QIHOO 360 TE QIHU 91.57 +4.38%
VIPSHOP HOLD VIPS 140.01 +3.49%
INVEST TECH- ITG 19.16 +3.34%
VERTEX ENERG VTNR 7.38 +3.07%